Good morning :)
Switch to
Place Order

Jubilant Pharmova Ltd

JUBLPHARMA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,678 cr, stock is ranked 275
Moderate RiskStock is 2.48x as volatile as Nifty
733.7023.65 (-3.12%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹11,678 cr, stock is ranked 275
Moderate RiskStock is 2.48x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
13.97
PB RatioPB Ratio
2.08
Dividend YieldDiv. Yield
0.79%
Sector PESector PE
37.87
Sector PBSector PB
5.67
Sector Div YldSctr Div Yld
0.66%

Forecast & RatingsDetailed Forecast 

89%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Jubilant Life Sciences Limited is a pharmaceutical and life sciences company.

Brands

Jubilant Life Sciences

Pharmaceutical company

Investor PresentationView older 

Jun 18, 2021

PDF
View Older Presentations

Brands

Jubilant Life Sciences

Pharmaceutical company

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20182019202020217.569.159.206.390.640.570.900.84
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Investor Presentation 
Announced OnJun 18, 2021

Jubilant Pharmova Limited has informed the Exchange about Investor Presentation | Download

Jubilant Pharmova Limited has informed the Exchange about Investor Presentation | Download

Updates 
Announced OnJun 15, 2021

Jubilant Pharmova Limited has informed the Exchange regarding 'We enclose a communication pertaining to manufacturing partnership for US production of COVID-19 Vaccine candidate,COVAXINᅡᆴ by Jubilant HollisterStier LLC, a step down subsidiary of the Company.'. | Download

Jubilant Pharmova Limited has informed the Exchange regarding 'We enclose a communication pertaining to manufacturing partnership for US production of COVID-19 Vaccine candidate,COVAXINᅡᆴ by Jubilant HollisterStier LLC, a step down subsidiary of the Company.'. | Download

Cash Dividend 
Ex. DateMar 9, 2020

Interim • Div/Share: ₹ 5

See all events